Empagliflozin + Linagliptin
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Empagliflozin
empagliflozin - Linagliptin
linagliptin
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| GlyxambiAUCAESEUGBHKMXSGTWUS | 25 mg / 5 mg / 10 mg | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Empagliflozin 10mg / Linagliptin 5mg tabletsAUGB | 10 mg / 5 mg / 25 mg | Boehringer Ingelheim Ltd |
| empagliflozin and linagliptinUS | 25 mg / 5 mg / 10 mg | Boehringer Ingelheim Pharmaceuticals, Inc. |
| linagliptina + empagliflozinaES | 5 mg / 10 mg / 25 mg | Boehringer Ingelheim International Gmbh |
| linagliptin + empagliflozinES | 5 mg / 10 mg / 25 mg | Boehringer Ingelheim International Gmbh |
| GLYXAMBI 10 mg/5 mg empagliflozin/linagliptin 10mg/5mg film coated tablet blister packAU | 10 mg / 5 mg / 25 mg | Boehringer Ingelheim Pty Ltd |
| 糖順平膜衣錠25/5毫克TW | — | 台灣百靈佳殷格翰股份有限公司 |
| 糖順平膜衣錠10/5毫克TW | — | 台灣百靈佳殷格翰股份有限公司 |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- ES · GLYXAMBI · 2 products · record
- GB · GLYXAMBI · 2 products · record
- US · GLYXAMBI · 2 products · record
- AU · GLYXAMBI · 2 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.